Cambridge Cognition Holdings PLC

Company Profile

• Business description

  Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.

• Contact

  Tunbridge Lane, Tunbridge Court
  Bottisham
  CambridgeCB25 9TU
  GBR

  T: +44 1223810700

  E: [email protected]

  https://www.cambridgecognition.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Health Information Services

  Fiscal Year End

  31 December 2026

  Employees

  74